Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://patents.google.com/patent/CN108711444A/en below:

CN108711444A - A kind of method and system for issuing electronic prescription

发明内容Contents of the invention

本发明实施例提供了一种开具电子处方的方法和系统，解决了现有的电 子处方开具方法，缺少考虑病人对电子处方的知情方面的需求，病人的参与 度不高，医师开错处方导致影响到病人的病情，甚至危及病人生命的问题得 不到改善的技术问题。The embodiment of the present invention provides a method and system for issuing electronic prescriptions, which solves the problem that the existing electronic prescription issuing methods lack consideration of the patient's need to know about electronic prescriptions, the patient's participation is not high, and doctors prescribe wrong prescriptions. Technical problems that affect the patient's condition and even endanger the life of the patient cannot be improved.

有鉴于此，本发明第一方面提供了一种开具电子处方的方法，所述方法 包括：In view of this, the first aspect of the present invention provides a method for issuing electronic prescriptions, the method comprising:

101：病人终端获取病人信息发送至药企终端，向所述药企终端发送药物 清单请求，获取所述药企终端返回的与所述病人信息对应的药物清单，其中， 所述病人信息包括所述病人的基本个人信息及症状；101: The patient terminal acquires patient information and sends it to the pharmaceutical company terminal, sends a drug list request to the pharmaceutical company terminal, and obtains the drug list corresponding to the patient information returned by the pharmaceutical company terminal, wherein the patient information includes all Describe the basic personal information and symptoms of the patient;

102：所述病人终端将所述病人信息和所述药物清单发送至医师终端，向 所述医师终端发送医师用药意见请求；102: The patient terminal sends the patient information and the drug list to the doctor terminal, and sends a doctor's medication opinion request to the doctor terminal;

103：所述病人终端获取到所述医师终端返回的与所述病人信息和药物清 单对应的医师用药意见，生成包括所述病人信息、所述药物清单和所述医师 用药意见的电子处方。103: The patient terminal obtains the doctor's medication advice corresponding to the patient information and drug list returned by the doctor terminal, and generates an electronic prescription including the patient information, the drug list, and the doctor's medication advice.

优选地，步骤103之后，还包括：Preferably, after step 103, it also includes:

104A：所述病人终端将所述电子处方发送至具有智能合约的医疗联盟区 块链，使得所述医疗联盟区块链对所述电子处方进行存储和共享。104A: The patient terminal sends the electronic prescription to the medical alliance blockchain with smart contracts, so that the medical alliance blockchain stores and shares the electronic prescription.

优选地，步骤103之后，还包括：Preferably, after step 103, it also includes:

104B：所述病人终端获取病人通过所述病人终端输入的对所述药物清单 和所述医师的评价，其中，所述评价为所述病人根据所述电子处方服用药物 后做出的反馈。104B: The patient terminal obtains the patient's evaluation of the drug list and the doctor's input through the patient terminal, wherein the evaluation is the feedback made by the patient after taking the drug according to the electronic prescription.

优选地，步骤101之后，步骤102之前，还包括：Preferably, after step 101 and before step 102, it also includes:

1012A：所述病人终端根据所述病人信息获取所述病人所属门诊类别，并 随机获取属于所述门诊类别的医师。1012A: The patient terminal acquires the outpatient category to which the patient belongs according to the patient information, and randomly acquires doctors belonging to the outpatient category.

优选地，步骤101之后，步骤102之前，还包括：Preferably, after step 101 and before step 102, it also includes:

1012B：所述病人终端根据所述病人信息获取所述病人所属门诊类别和所 述门诊类别的可选医师名单，获取到所述病人根据可选医师名单指定的医师。1012B: According to the patient information, the patient terminal obtains the outpatient category to which the patient belongs and the list of available physicians of the outpatient category, and acquires the physician specified by the patient according to the list of available physicians.

优选地，所述病人信息包括所述病人的病人数字签名，所述药物清单包 括提供所述药物清单的药企的药企数字签名，所述医师用药意见包括所述医 师的医师数字签名。Preferably, the patient information includes the patient's digital signature of the patient, the drug list includes the digital signature of the pharmaceutical company that provided the drug list, and the physician's medication advice includes the physician's digital signature of the physician.

优选地，步骤101之前，还包括：Preferably, before step 101, it also includes:

100：病人终端和/或药企终端和/或医师终端通过授权认证中心进行认证。100: The patient terminal and/or the pharmaceutical company terminal and/or the physician terminal are authenticated by the authorized authentication center.

本发明第二方面提供一种开具电子处方的系统，用于实现上述的开具电 子处方的方法，其特征在于，包括：病人终端、药企终端和医师终端；The second aspect of the present invention provides a system for issuing electronic prescriptions, which is used to implement the above-mentioned method for issuing electronic prescriptions, which is characterized in that it includes: a patient terminal, a pharmaceutical company terminal and a doctor terminal;

所述病人终端，用于获取病人信息发送至药企终端，向所述药企终端发 送药物清单请求，获取所述药企终端返回的与所述病人信息对应的药物清单， 其中，所述病人信息包括所述病人的基本个人信息及症状；The patient terminal is used to obtain patient information and send it to a pharmaceutical company terminal, send a drug list request to the pharmaceutical company terminal, and obtain a drug list corresponding to the patient information returned by the pharmaceutical company terminal, wherein the patient Information includes basic personal information and symptoms of the patient in question;

所述病人终端，还用于将所述病人信息和所述药物清单发送至医师终端， 向所述医师终端发送医师用药意见请求；The patient terminal is also used to send the patient information and the drug list to the doctor terminal, and send the doctor's medication opinion request to the doctor terminal;

所述病人终端，还用于获取到所述医师终端返回的与所述病人信息和药 物清单对应的医师用药意见，生成包括所述病人信息、所述药物清单和所述 医师用药意见的电子处方；The patient terminal is also used to obtain the doctor's medication advice corresponding to the patient information and drug list returned by the doctor terminal, and generate an electronic prescription including the patient information, the drug list, and the doctor's medication advice ;

所述药企终端，用于获取所述病人终端发送的药物清单请求和所述病人 信息，并向所述病人终端返回药物清单；The pharmaceutical enterprise terminal is used to obtain the drug list request and the patient information sent by the patient terminal, and return the drug list to the patient terminal;

所述医师终端，用于获取所述病人终端发送的所述医师用药意见请求， 所述病人信息和所述药物清单，向所述病人终端返回医师用药意见。The physician terminal is configured to obtain the doctor's medication opinion request sent by the patient terminal, the patient information and the drug list, and return the physician's medication opinion to the patient terminal.

优选地，所述系统还包括：医疗联盟区块链；Preferably, the system also includes: medical alliance block chain;

所述医疗联盟区块链，用于对所述电子处方进行存储和共享。The medical alliance block chain is used to store and share the electronic prescription.

优选地，所述系统还包括：授权认证中心；Preferably, the system further includes: an authorized authentication center;

所述授权认证中心，用于对病人终端和/或药企终端和/或医师终端进行认 证。The authorized authentication center is used to authenticate patient terminals and/or pharmaceutical company terminals and/or physician terminals.

从以上技术方案可以看出，本发明具有以下优点：As can be seen from the above technical solutions, the present invention has the following advantages:

本发明提供的一种开具电子处方的方法，通过病人终端将病人信息发送 给药企终端，由药企终端向病人终端提供药物清单，病人终端获取到药企终 端发送的与病人信息对应的药物清单之后，将药物清单和病人信息发送至医 师终端，医师终端将医师开具的包括与病人信息和药物清单对应的医师用药 意见返回给病人终端，最后由病人终端生成包括病人信息、药物清单和医师 用药意见的电子处方；在电子处方的整个开具过程中，病人通过病人终端参 与了电子处方开具的每一个过程，使得病人可以通过病人终端对电子处方的 开具过程拥有知情的能力，满足了病人对电子处方的知情需求。同时，医师 的医师用药意见是根据病人的病人信息和药企的药物清单提供的，在病人根 据电子处方进行用药前，病人通过病人终端获取到的药企终端返回的药物清 单，可以了解到病人所适合使用的药物，对电子处方里的药物进行核对，在 对电子处方确认之后再进行服用，能够在一定程度上使得医师开错处方导致 影响到病人的病情，甚至危及病人生命的问题得到改善，解决了现有的电子 处方开具方法，缺少考虑病人对电子处方的知情方面的需求，病人的参与度不高，医师开错处方导致影响到病人的病情，甚至危及病人生命的问题得不 到改善的技术问题。A method for issuing electronic prescriptions provided by the present invention, the patient information is sent to the drug company terminal through the patient terminal, the drug company terminal provides the drug list to the patient terminal, and the patient terminal obtains the drug corresponding to the patient information sent by the drug company terminal After the list, the drug list and patient information are sent to the doctor's terminal, and the doctor's terminal returns the doctor's medication opinion issued by the doctor, including the corresponding patient information and drug list, to the patient terminal. Electronic prescription for medication advice; in the entire process of issuing electronic prescriptions, patients participate in every process of electronic prescription issuance through patient terminals, so that patients can have the ability to know about the issuance process of electronic prescriptions through patient terminals, which meets the needs of patients. The need to know for electronic prescribing. At the same time, the doctor's doctor's medication opinion is provided based on the patient's patient information and the drug list of the pharmaceutical company. Before the patient takes the drug according to the electronic prescription, the patient can learn about the patient's drug list through the patient's terminal and the drug list returned by the pharmaceutical company's terminal. For the drugs that are suitable for use, check the drugs in the electronic prescription and take them after confirming the electronic prescription. To a certain extent, the problem that the doctor prescribes the wrong prescription that affects the patient's condition and even endangers the patient's life can be improved. , to solve the existing electronic prescription issuing method, lack of consideration of the patient's demand for information on the electronic prescription, the patient's participation is not high, and the doctor prescribes the wrong prescription, which will affect the patient's condition and even endanger the patient's life. Improved technical issues.

具体实施方式Detailed ways

为了使本技术领域的人员更好地理解本发明方案，下面将结合本发明实 施例中的附图，对本发明实施例中的技术方案进行清楚、完整地描述，显然， 所描述的实施例仅是本发明的一部分实施例，而不是全部的实施例。基于本 发明中的实施例，本领域普通技术人员在缺少做出创造性劳动的前提下所获 得的所有其他实施例，都属于本发明保护的范围。In order to enable those skilled in the art to better understand the solutions of the present invention, the following will clearly and completely describe the technical solutions in the embodiments of the present invention in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only It is a part of embodiments of the present invention, but not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.

本发明设计了一种开具电子处方的方法和系统，通过病人终端将病人信 息发送给药企终端，由药企终端向病人终端提供药物清单，病人终端获取到 药企终端发送的与病人信息对应的药物清单之后，将药物清单和病人信息发 送至医师终端，医师终端将医师开具的包括与病人信息和药物清单对应的医 师用药意见返回给病人终端，最后由病人终端生成包括病人信息、药物清单 和医师用药意见的电子处方，解决了现有的电子处方开具方法，缺少考虑病 人对电子处方的知情方面的需求，病人的参与度不高，医师开错处方导致影 响到病人的病情，甚至危及病人生命的问题得不到改善的技术问题。The present invention designs a method and system for issuing electronic prescriptions. The patient information is sent to the drug company terminal through the patient terminal, and the drug company terminal provides the patient terminal with a list of drugs. The patient terminal obtains the information corresponding to the patient information sent by the drug company terminal. After the drug list, the drug list and patient information are sent to the doctor terminal, and the doctor terminal returns the doctor's medication opinion issued by the doctor, including the corresponding patient information and drug list, to the patient terminal, and finally the patient terminal generates the patient information, drug list The electronic prescription with doctor's advice on medication solves the existing electronic prescription issuing method, which lacks consideration of the patient's demand for information on electronic prescription, and the patient's participation is not high. The problems of the patient's life are not improved by the technical problems.

为了便于理解，请参阅图1，本发明提供的一种开具电子处方的方法的第 一个实施例，包括：For ease of understanding, please refer to Fig. 1, a kind of first embodiment of the method for issuing an electronic prescription provided by the present invention, comprising:

步骤101：病人终端获取病人信息发送至药企终端，向药企终端发送药物 清单请求，获取药企终端返回的与病人信息对应的药物清单，其中，病人信 息包括病人的基本个人信息及症状。Step 101: The patient terminal obtains the patient information and sends it to the pharmaceutical company terminal, sends a drug list request to the pharmaceutical company terminal, and obtains the drug list corresponding to the patient information returned by the pharmaceutical company terminal. The patient information includes the patient's basic personal information and symptoms.

需要说明的是，病人通过病人终端填写病人信息，使得病人终端获得病 人信息，病人信息应包括病人的基本信息，如年龄、性别、出生年月、历史 病史和过敏药物等情况，还应包括病人目前的不适应症状，如腹部疼痛程度、 是否头晕和伤痛部位等。病人终端获取到病人信息之后，将病人信息发送至 药企终端，同时向药企终端发送药物清单请求，并获取到药企终端返回的药 物清单。可以理解的是，为打破传统的药物清单只能是医院提供，容易导致 药物不全的局限性，提供药物的药企可以是一个以上的满足药企智能合约的药企联盟中的所有药企提供，同时，全面性的药物清单也可以在一定程度上 减少医师犯错的几率。It should be noted that the patient fills in the patient information through the patient terminal, so that the patient terminal can obtain the patient information. The patient information should include the basic information of the patient, such as age, gender, date of birth, historical medical history, and allergies. The current unsuitable symptoms, such as the degree of abdominal pain, dizziness and pain site, etc. After the patient terminal obtains the patient information, it sends the patient information to the pharmaceutical company terminal, at the same time sends a drug list request to the pharmaceutical company terminal, and obtains the drug list returned by the pharmaceutical company terminal. It is understandable that in order to break the traditional drug list that can only be provided by hospitals, which may easily lead to the limitation of incomplete drugs, the pharmaceutical companies that provide drugs can be provided by more than one pharmaceutical company in the pharmaceutical company alliance that satisfies the pharmaceutical company’s smart contract. , At the same time, a comprehensive drug list can also reduce the chance of doctors making mistakes to a certain extent.

步骤102：病人终端将病人信息和药物清单发送至医师终端，向医师终端 发送医师用药意见请求。Step 102: The patient terminal sends the patient information and drug list to the doctor terminal, and sends the doctor's medication opinion request to the doctor terminal.

需要说明的是，在病人终端获取到药企终端返回的药物清单之后，病人 终端将将病人信息和药物清单发送至医师终端，向医师终端发送医师用药意 见请求，并获取医师终端返回的医师用药意见。医师用药意见应当是医师通 过医师终端获得病人信息和药物清单之后，根据病人信息和药物清单作出的 对病人进行治疗的意见。It should be noted that after the patient terminal obtains the drug list returned by the pharmaceutical company terminal, the patient terminal will send the patient information and drug list to the doctor terminal, send the doctor's medication opinion request to the doctor terminal, and obtain the doctor's medication information returned by the doctor terminal. Opinion. Physician’s medication opinion should be the doctor’s opinion on treating the patient based on the patient’s information and drug list after obtaining the patient’s information and drug list through the doctor’s terminal.

步骤103：病人终端获取到医师终端返回的与病人信息和药物清单对应的 医师用药意见，生成包括病人信息、药物清单和医师用药意见的电子处方。Step 103: The patient terminal obtains the doctor's medication advice corresponding to the patient information and drug list returned by the doctor terminal, and generates an electronic prescription including the patient information, drug list, and doctor's medication advice.

需要说明的是，在医师完成医师用药意见之后，通过医师终端将医师用 药意见发送给病人终端，病人终端生成包括病人信息、药物清单和医师用药 意见的电子处方，在病人对电子处方确认无误之后再行服用电子处方提供的 药物。It should be noted that after the doctor completes the doctor's medication opinion, the doctor's medication opinion is sent to the patient terminal through the doctor's terminal, and the patient terminal generates an electronic prescription including patient information, drug list and doctor's medication opinion. After the patient confirms that the electronic prescription is correct Take the medicine provided by the electronic prescription again.

本发明实施例中，提供了一种开具电子处方的方法，通过病人终端将病 人信息发送给药企终端，由药企终端向病人终端提供药物清单，病人终端获 取到药企终端发送的与病人信息对应的药物清单之后，将药物清单和病人信 息发送至医师终端，医师终端将医师开具的包括与病人信息和药物清单对应 的医师用药意见返回给病人终端，最后由病人终端生成包括病人信息、药物 清单和医师用药意见的电子处方；在电子处方的整个开具过程中，病人通过 病人终端参与了电子处方开具的每一个过程，使得病人可以通过病人终端对电子处方的开具过程拥有知情的能力，满足了病人对电子处方的知情需求。 同时，医师的医师用药意见是根据病人的病人信息和药企的药物清单提供的， 在病人根据电子处方进行用药前，病人通过病人终端获取到的药企终端返回 的药物清单，可以了解到病人所适合使用的药物，对电子处方里的药物进行 核对，在对电子处方确认之后再进行服用，能够在一定程度上使得医师开错 处方导致影响到病人的病情，甚至危及病人生命的问题得到改善，解决了现 有的电子处方开具方法，缺少考虑病人对电子处方的知情方面的需求，病人的参与度不高，医师开错处方导致影响到病人的病情，甚至危及病人生命的 问题得不到改善的技术问题。In the embodiment of the present invention, a method for issuing an electronic prescription is provided. The patient information is sent to the drug company terminal through the patient terminal, and the drug company terminal provides the patient terminal with a list of drugs. After the drug list corresponding to the information, the drug list and patient information are sent to the doctor terminal, and the doctor terminal returns the doctor's medication opinion issued by the doctor including the doctor's medication opinion corresponding to the patient information and the drug list to the patient terminal, and finally the patient terminal generates information including patient information, Electronic prescription of drug list and doctor's medication opinion; in the whole process of issuing electronic prescription, the patient participates in every process of electronic prescription issuing through the patient terminal, so that the patient can have the ability to know the electronic prescription issuing process through the patient terminal, It satisfies the patient's demand for informed information on electronic prescriptions. At the same time, the doctor's doctor's medication opinion is provided based on the patient's patient information and the drug list of the pharmaceutical company. Before the patient takes the drug according to the electronic prescription, the patient can understand the patient's drug list through the patient's terminal and the drug list returned by the pharmaceutical company's terminal. For the drugs that are suitable for use, check the drugs in the electronic prescription and take them after confirming the electronic prescription. To a certain extent, the problem that the doctor prescribes the wrong prescription that affects the patient's condition and even endangers the patient's life can be improved. , to solve the existing electronic prescription issuing method, lack of consideration of the patient's demand for information on the electronic prescription, the patient's participation is not high, and the doctor prescribes the wrong prescription, which will affect the patient's condition and even endanger the patient's life. Improved technical issues.

为了便于理解，请参阅图2，本发明提供的一种开具电子处方的方法的第 二个实施例，包括：For ease of understanding, please refer to Fig. 2, a kind of second embodiment of the method for issuing electronic prescription provided by the present invention, comprising:

步骤201：病人终端获取病人信息发送至药企终端，向药企终端发送药物 清单请求，获取药企终端返回的与病人信息对应的药物清单，其中，病人信 息包括病人的基本个人信息及症状。Step 201: The patient terminal obtains the patient information and sends it to the pharmaceutical company terminal, sends a drug list request to the pharmaceutical company terminal, and obtains the drug list corresponding to the patient information returned by the pharmaceutical company terminal. The patient information includes the patient's basic personal information and symptoms.

需要说明的是，步骤201与步骤101一致，在此不进行详细赘述。It should be noted that step 201 is consistent with step 101, and will not be described in detail here.

步骤202：病人终端将病人信息和药物清单发送至医师终端，向医师终端 发送医师用药意见请求。Step 202: The patient terminal sends the patient information and drug list to the doctor terminal, and sends the doctor's medication opinion request to the doctor terminal.

需要说明的是，步骤202与步骤102一致，在此不进行详细赘述。It should be noted that step 202 is consistent with step 102 and will not be described in detail here.

步骤203：病人终端获取到医师终端返回的与病人信息和药物清单对应的 医师用药意见，生成包括病人信息、药物清单和医师用药意见的电子处方。Step 203: The patient terminal obtains the doctor's medication advice corresponding to the patient information and the drug list returned by the doctor terminal, and generates an electronic prescription including the patient information, the drug list, and the doctor's medication advice.

需要说明的是，步骤203与步骤103一致，在此不进行详细赘述。It should be noted that step 203 is consistent with step 103 and will not be described in detail here.

步骤204：病人终端将电子处方发送至具有智能合约的医疗联盟区块链， 使得医疗联盟区块链对电子处方进行存储和共享。Step 204: The patient terminal sends the electronic prescription to the medical alliance blockchain with smart contracts, so that the medical alliance blockchain can store and share the electronic prescription.

需要说明的是，区块链技术是利用块链式数据结构来验证与存储数据、 利用分布式节点共识算法来生成和更新数据、利用密码学的方式保证数据传 输和访问的安全、利用由自动化脚本代码组成的智能合约来编程和操作的一 种全新的分布式基础架构与计算方式，具有去中心化、不可篡改、过程透明 可追踪等优点。其中，智能合约最早是密码学家Nick Szabo在1994年提出的 以数字形式定义的一系列承诺，包括合约参与方可以在上面执行这些承诺的 协议。It should be noted that blockchain technology uses block chain data structures to verify and store data, uses distributed node consensus algorithms to generate and update data, and uses cryptography to ensure the security of data transmission and access. A brand-new distributed infrastructure and computing method programmed and operated by smart contracts composed of script codes, which has the advantages of decentralization, non-tampering, and transparent and traceable processes. Among them, smart contracts were first proposed by cryptographer Nick Szabo in 1994 as a series of commitments defined in digital form, including agreements on which contract participants can execute these commitments.

在医师完成医师用药意见之后，通过医师用户终端将医师用药意见发送 给病人用户终端，病人用户终端生成包括病人信息、药物清单和医师用药意 见的电子处方，在病人对电子处方确认无误之后，病人用户终端将电子处方 发送到具有智能合约的医疗联盟区块链，医疗联盟区块链触发智能合约，对 电子处方进行存储和共享，满足智能合约的病人、医师和药企均可通过用户 终端获得在医疗联盟区块链里的包括该病人、医师和药企的电子处方，医疗 联盟区块链里的电子处方不可篡改，安全可靠。After the doctor completes the doctor's medication opinion, the doctor's medication opinion is sent to the patient user terminal through the physician user terminal, and the patient user terminal generates an electronic prescription including patient information, drug list and doctor's medication opinion. After the patient confirms that the electronic prescription is correct, the patient The user terminal sends the electronic prescription to the medical alliance blockchain with a smart contract, and the medical alliance blockchain triggers the smart contract to store and share the electronic prescription. Patients, doctors and pharmaceutical companies that meet the smart contract can obtain it through the user terminal The electronic prescriptions in the medical alliance blockchain include the patient, physician and pharmaceutical company. The electronic prescriptions in the medical alliance blockchain cannot be tampered with and are safe and reliable.

进一步地，病人信息包括病人的病人数字签名，药物清单包括提供药物 清单的药企的药企数字签名，医师用药意见包括医师的医师数字签名。Further, the patient information includes the patient's digital signature, the drug list includes the digital signature of the pharmaceutical company that provided the drug list, and the physician's medication opinion includes the physician's digital signature.

需要说明的是，病人信息除了病人的个人信息和症状之外，还应包包括 病人的病人数字签名，以为病人信息的来源提供可靠的依据，防止有人恶意 提供看病信息；药物清单除了包括药物信息之外，还应包包括提供药物清单 的药企的药企数字签名，以为该药物清单提供真实依据，防止药物清单被恶 意冒用，无法追根溯源。同理，医师的医师用药意见中也应当包包括提供用 药意见的医师数字签名，以为该医师用药意见提供真实凭据，防止医师用药 意见被恶意冒用，防止病人或药企等对医师用药意见存在疑问时，无法找到 开具该医师用药意见的医师。It should be noted that in addition to the patient's personal information and symptoms, the patient information should also include the patient's digital signature to provide a reliable basis for the source of the patient information and prevent anyone from maliciously providing medical information; In addition, the digital signature of the pharmaceutical company that provided the drug list should also be included to provide a real basis for the drug list and prevent the drug list from being used maliciously and cannot be traced back to the source. In the same way, the physician's medication opinion should also include the digital signature of the physician who provided the medication opinion, so as to provide real evidence for the physician's medication opinion, prevent the doctor's medication opinion from being maliciously used, and prevent patients or pharmaceutical companies from having a doctor's medication opinion. When in doubt, the physician who issued the physician's medication opinion cannot be found.

为了便于理解，请参阅图3，本发明提供的一种开具电子处方的方法的第 三个实施例，包括：For ease of understanding, please refer to Fig. 3, a kind of third embodiment of the method for issuing electronic prescription provided by the present invention, comprising:

步骤301：病人终端获取病人信息发送至药企终端，向药企终端发送药物 清单请求，获取药企终端返回的与病人信息对应的药物清单，其中，病人信 息包括病人的基本个人信息及症状。Step 301: The patient terminal obtains the patient information and sends it to the pharmaceutical company terminal, sends a drug list request to the pharmaceutical company terminal, and obtains the drug list corresponding to the patient information returned by the pharmaceutical company terminal. The patient information includes the patient's basic personal information and symptoms.

需要说明的是，步骤301与步骤101一致，在此不进行详细赘述。It should be noted that step 301 is consistent with step 101 and will not be described in detail here.

步骤302：病人终端将病人信息和药物清单发送至医师终端，向医师终端 发送医师用药意见请求。Step 302: The patient terminal sends the patient information and drug list to the doctor terminal, and sends the doctor's medication opinion request to the doctor terminal.

需要说明的是，步骤302与步骤102一致，在此不进行详细赘述。It should be noted that step 302 is consistent with step 102 and will not be described in detail here.

步骤303：病人终端获取到医师终端返回的与病人信息和药物清单对应的 医师用药意见，生成包括病人信息、药物清单和医师用药意见的电子处方。Step 303: The patient terminal obtains the doctor's medication advice corresponding to the patient information and the drug list returned by the doctor terminal, and generates an electronic prescription including the patient information, the drug list, and the doctor's medication advice.

需要说明的是，步骤303与步骤103一致，在此不进行详细赘述。It should be noted that step 303 is consistent with step 103 and will not be described in detail here.

步骤304：病人终端获取病人通过病人终端输入的对药物清单和医师的评 价，其中，评价为病人根据电子处方服用药物后做出的反馈。Step 304: The patient terminal obtains the patient's input on the drug list and the doctor's evaluation through the patient terminal, wherein the evaluation is the feedback made by the patient after taking the drug according to the electronic prescription.

需要说明的是，对于新药物的研发，需要大量可靠的药物临床试验数据 来判定药物的有效性和安全性，只有验证合格的新药物才能批准上市，在上 市后，还需要关注在大范围人群应用后的疗效和不良反应监测数据，对药物 做一些补充说明等，出现严重问题还要强制要求药物下架。在病人获取到电 子处方并服用电子处方提供的药物之后，对药物和医师进行评价，这些评价 可以为研发出更多具有更好疗效的新药物提供有力的数据支持，还可以对医 师的业务水平做出一个评判，同时还可以根据病人反馈的评价情况对假药追根溯源，打击制造假药的违法机构。It should be noted that for the research and development of new drugs, a large amount of reliable drug clinical trial data is needed to determine the effectiveness and safety of drugs. Only qualified new drugs can be approved for marketing. The curative effect and adverse reaction monitoring data after application, some supplementary explanations for the drug, etc., and the drug must be removed from the shelf if there are serious problems. After the patient obtains the electronic prescription and takes the drug provided by the electronic prescription, the drug and the doctor are evaluated. These evaluations can provide strong data support for the development of more new drugs with better efficacy, and can also improve the professional level of the doctor. Make a judgment, and at the same time, trace the source of counterfeit medicines based on the evaluation of patients' feedback, and crack down on illegal institutions that manufacture counterfeit medicines.

可以理解的是，本发明中的病人通过病人终端输入的对药物订单和医师 的评价，这个评价是与电子处方一一对应的，评价的类型可以是文字评价， 也可以是打分评价，还可以是语音评价等，在此不对评价类型做具体限定。It can be understood that the patient in the present invention inputs the evaluation of the drug order and the doctor through the patient terminal. This evaluation is in one-to-one correspondence with the electronic prescription. The type of evaluation can be text evaluation, scoring evaluation, or It is a voice evaluation, etc., and the evaluation type is not specifically limited here.

进一步地，病人信息包括病人的病人数字签名，药物清单包括提供药物 清单的药企的药企数字签名，医师用药意见包括医师的医师数字签名。Further, the patient information includes the patient's digital signature, the drug list includes the digital signature of the pharmaceutical company that provided the drug list, and the physician's medication opinion includes the physician's digital signature.

需要说明的是，病人信息除了病人的个人信息和症状之外，还应包包括 病人的病人数字签名，以为病人信息的来源提供可靠的依据，防止有人恶意 提供看病信息；药物清单除了包括药物信息之外，还应包包括提供药物清单 的药企的药企数字签名，以为该药物清单提供真实依据，防止药物清单被恶 意冒用，无法追根溯源。同理，医师的医师用药意见中也应当包包括提供用 药意见的医师数字签名，以为该医师用药意见提供真实凭据，防止医师用药 意见被恶意冒用，防止病人或药企等对医师用药意见存在疑问时，无法找到 开具该医师用药意见的医师。It should be noted that in addition to the patient's personal information and symptoms, the patient information should also include the patient's digital signature to provide a reliable basis for the source of the patient information and prevent anyone from maliciously providing medical information; In addition, the digital signature of the pharmaceutical company that provided the drug list should also be included to provide a real basis for the drug list and prevent the drug list from being used maliciously and cannot be traced back to the source. In the same way, the physician's medication opinion should also include the digital signature of the physician who provided the medication opinion, so as to provide real evidence for the physician's medication opinion, prevent the doctor's medication opinion from being maliciously used, and prevent patients or pharmaceutical companies from having a doctor's medication opinion. When in doubt, the physician who issued the physician's medication opinion cannot be found.

为了便于理解，请参阅图4，本发明提供的一种开具电子处方的方法的第 四个实施例，包括：For ease of understanding, please refer to Fig. 4, a kind of fourth embodiment of the method for issuing an electronic prescription provided by the present invention, comprising:

步骤401：病人终端获取病人信息发送至药企终端，向药企终端发送药物 清单请求，获取药企终端返回的与病人信息对应的药物清单，其中，病人信 息包括病人的基本个人信息及症状。Step 401: The patient terminal obtains the patient information and sends it to the pharmaceutical company terminal, sends a drug list request to the pharmaceutical company terminal, and obtains the drug list corresponding to the patient information returned by the pharmaceutical company terminal. The patient information includes the patient's basic personal information and symptoms.

需要说明的是，步骤401与步骤101一致，在此不进行详细赘述。It should be noted that step 401 is consistent with step 101 and will not be described in detail here.

步骤402：病人终端根据病人信息获取病人所属门诊类别，并随机获取属 于门诊类别的医师。Step 402: The patient terminal obtains the outpatient category of the patient according to the patient information, and randomly obtains the doctors belonging to the outpatient category.

需要说明的是，在获取病人信息和药物清单之后，根据病人信息和/或药 物清单确定门诊类别，如皮肤科、骨科、妇科和外科等，并根据门诊类别对 所属门诊类别的医师随机为病人指定主治医师，例如，获取到A病人的病人 信息之后，根据病人信息判断出A病人应看的门诊类别为皮肤科，而皮肤科 的医师有B、C、D和E四位，病人用户终端可以在B、C、D和E这四位医 师中随机选择一位作为A病人的主治医师。It should be noted that after the patient information and drug list are obtained, the outpatient category is determined according to the patient information and/or drug list, such as dermatology, orthopedics, gynecology, and surgery, and according to the outpatient category, the physicians belonging to the outpatient category are randomly selected as patients. Designate the attending physician. For example, after obtaining the patient information of patient A, it is determined based on the patient information that the outpatient category that patient A should see is dermatology, and there are four physicians in the dermatology department: B, C, D, and E. The patient user terminal One of the four physicians B, C, D, and E can be randomly selected as the attending physician of patient A.

步骤403：病人终端将病人信息和药物清单发送至医师终端，向医师终端 发送医师用药意见请求。Step 403: The patient terminal sends the patient information and drug list to the doctor terminal, and sends the doctor's medication opinion request to the doctor terminal.

需要说明的是，步骤403与步骤102一致，在此不进行详细赘述。It should be noted that step 403 is consistent with step 102 and will not be described in detail here.

步骤404：病人终端获取到医师终端返回的与病人信息和药物清单对应的 医师用药意见，生成包括病人信息、药物清单和医师用药意见的电子处方。Step 404: The patient terminal obtains the doctor's medication advice corresponding to the patient information and drug list returned by the doctor terminal, and generates an electronic prescription including the patient information, drug list, and doctor's medication advice.

需要说明的是，步骤404与步骤103一致，在此不进行详细赘述。It should be noted that step 404 is consistent with step 103 and will not be described in detail here.

步骤405：病人终端获取病人对药物清单和医师的评价，其中，评价为病 人根据电子处方服用药物后做出的反馈。Step 405: The patient terminal obtains the patient's evaluation of the drug list and the doctor, wherein the evaluation is the feedback made by the patient after taking the drug according to the electronic prescription.

需要说明的是，步骤405与步骤304一致，在此不进行详细赘述。It should be noted that step 405 is consistent with step 304 and will not be described in detail here.

进一步地，病人信息包括病人的病人数字签名，药物清单包括提供药物 清单的药企的药企数字签名，医师用药意见包括医师的医师数字签名。Further, the patient information includes the patient's digital signature, the drug list includes the digital signature of the pharmaceutical company that provided the drug list, and the physician's medication opinion includes the physician's digital signature.

需要说明的是，病人信息除了病人的个人信息和症状之外，还应包包括 病人的病人数字签名，以为病人信息的来源提供可靠的依据，防止有人恶意 提供看病信息；药物清单除了包括药物信息之外，还应包包括提供药物清单 的药企的药企数字签名，以为该药物清单提供真实依据，防止药物清单被恶 意冒用，无法追根溯源。同理，医师的医师用药意见中也应当包包括提供用 药意见的医师数字签名，以为该医师用药意见提供真实凭据，防止医师用药 意见被恶意冒用，防止病人或药企等对医师用药意见存在疑问时，无法找到 开具该医师用药意见的医师。It should be noted that in addition to the patient's personal information and symptoms, the patient information should also include the patient's digital signature to provide a reliable basis for the source of the patient information and prevent anyone from maliciously providing medical information; In addition, the digital signature of the pharmaceutical company that provided the drug list should also be included to provide a real basis for the drug list and prevent the drug list from being used maliciously and cannot be traced back to the source. In the same way, the physician's medication opinion should also include the digital signature of the physician who provided the medication opinion, so as to provide real evidence for the physician's medication opinion, prevent the doctor's medication opinion from being maliciously used, and prevent patients or pharmaceutical companies from having a doctor's medication opinion. When in doubt, the physician who issued the physician's medication opinion cannot be found.

为了便于理解，请参阅图5，本发明提供的一种开具电子处方的方法的第 五个实施例，包括：For ease of understanding, please refer to Fig. 5, a kind of fifth embodiment of the method for issuing an electronic prescription provided by the present invention, comprising:

步骤501：病人终端根据病人信息获取病人信息发送至药企终端，向药企 终端发送药物清单请求，获取药企终端返回的与病人信息对应的药物清单， 其中，病人信息包括病人的基本个人信息及症状。Step 501: The patient terminal obtains the patient information according to the patient information and sends it to the pharmaceutical company terminal, sends a drug list request to the pharmaceutical company terminal, and obtains the drug list corresponding to the patient information returned by the pharmaceutical company terminal, wherein the patient information includes the basic personal information of the patient and symptoms.

需要说明的是，步骤501与步骤101一致，在此不进行详细赘述。It should be noted that step 501 is consistent with step 101 and will not be described in detail here.

步骤502：病人终端获取病人所属门诊类别和门诊类别的可选医师名单， 获取到病人根据可选医师名单指定的医师。Step 502: The patient terminal obtains the outpatient category to which the patient belongs and the list of available doctors for the outpatient category, and obtains the doctor specified by the patient according to the list of available doctors.

需要说明的是，在病人用户终端在获取到病人信息和药物清单之后，根 据病人信息和药物清单确定门诊类别，如皮肤科、骨科、妇科和外科等，并 将所属门诊类别的所有医师名单发送给病人，由病人自行完成对医师的选择， 例如，获取到A病人的病人信息和药物清单之后，根据病人信息和/或药物清 单判断出A病人应看的门诊类别为皮肤科，而皮肤科的医师有B、C、D和E 四位，病人用户终端可以将B、C、D和E这四位医师名单进行显示，病人A选择其中一位医师作为A病人的主治医师。It should be noted that after the patient user terminal obtains the patient information and the list of medicines, it determines the outpatient category according to the patient information and the list of medicines, such as dermatology, orthopedics, gynecology and surgery, etc., and sends the list of all physicians belonging to the outpatient category to For the patient, the patient completes the selection of the doctor by himself. For example, after obtaining the patient information and drug list of patient A, it is judged that the outpatient category that patient A should see is dermatology according to the patient information and/or drug list, and the dermatology department There are four physicians B, C, D, and E. The patient user terminal can display the list of these four physicians B, C, D, and E. Patient A chooses one of the physicians as the attending physician of patient A.

步骤503：病人终端将病人信息和药物清单发送至医师终端，向医师终端 发送医师用药意见请求。Step 503: The patient terminal sends the patient information and drug list to the doctor terminal, and sends the doctor's medication opinion request to the doctor terminal.

需要说明的是，步骤503与步骤403一致，在此不进行详细赘述。It should be noted that step 503 is consistent with step 403 and will not be described in detail here.

步骤504：病人终端获取到医师终端返回的与病人信息和药物清单对应的 医师用药意见，生成包括病人信息、药物清单和医师用药意见的电子处方。Step 504: The patient terminal obtains the doctor's medication advice corresponding to the patient information and the drug list returned by the doctor terminal, and generates an electronic prescription including the patient information, the drug list, and the doctor's medication advice.

需要说明的是，步骤504与步骤404一致，在此不进行详细赘述。It should be noted that step 504 is consistent with step 404, and will not be described in detail here.

步骤505：病人终端获取病人对药物清单和医师的评价，其中，评价为病 人根据电子处方服用药物后做出的反馈。Step 505: The patient terminal obtains the patient's evaluation of the drug list and the doctor, wherein the evaluation is the feedback made by the patient after taking the drug according to the electronic prescription.

需要说明的是，步骤505与步骤405一致，在此不进行详细赘述。It should be noted that step 505 is consistent with step 405 and will not be described in detail here.

进一步地，病人信息包括病人的病人数字签名，药物清单包括提供药物 清单的药企的药企数字签名，医师用药意见包括医师的医师数字签名。Further, the patient information includes the patient's digital signature, the drug list includes the digital signature of the pharmaceutical company that provided the drug list, and the physician's medication opinion includes the physician's digital signature.

需要说明的是，病人信息除了病人的个人信息和症状之外，还应包包括 病人的病人数字签名，以为病人信息的来源提供可靠的依据，防止有人恶意 提供看病信息；药物清单除了包括药物信息之外，还应包包括提供药物清单 的药企的药企数字签名，以为该药物清单提供真实依据，防止药物清单被恶 意冒用，无法追根溯源。同理，医师的医师用药意见中也应当包包括提供用 药意见的医师数字签名，以为该医师用药意见提供真实凭据，防止医师用药 意见被恶意冒用，防止病人或药企等对医师用药意见存在疑问时，无法找到 开具该医师用药意见的医师。It should be noted that in addition to the patient's personal information and symptoms, the patient information should also include the patient's digital signature to provide a reliable basis for the source of the patient information and prevent someone from maliciously providing medical information; In addition, the digital signature of the pharmaceutical company that provided the drug list should also be included to provide a true basis for the drug list and prevent the drug list from being used maliciously and cannot be traced back to the source. Similarly, the physician's medication opinion should also include the digital signature of the physician who provided the medication opinion, so as to provide real evidence for the physician's medication opinion, prevent the doctor's medication opinion from being maliciously used, and prevent patients or pharmaceutical companies from having any opinions on the doctor's medication opinion. When in doubt, the physician who issued the physician's medication opinion cannot be found.

为了便于理解，请参阅图6，本发明提供的一种开具电子处方的方法的第 六个实施例，包括：For ease of understanding, please refer to Figure 6, a sixth embodiment of a method for issuing an electronic prescription provided by the present invention, including:

步骤600：授权认证中心对病人终端和/或药企终端和/或医师终端进行认 证。Step 600: Authorize the authentication center to authenticate the patient terminal and/or the pharmaceutical company terminal and/or the doctor terminal.

需要说明的是，为保证电子处方的信息安全性，在病人或药企或医师通 过终端使用电子处方前，需要通过授权认证中心对终端进行身份认证，只有 通过认证授权的终端才能获取对电子处方的操作权限，其中，授权认证中心 对终端的认证方式可以是通过认证终端发送过来的病人或药企或医师的公钥 的合法性。It should be noted that in order to ensure the information security of electronic prescriptions, before patients, pharmaceutical companies or doctors use electronic prescriptions through terminals, they need to authenticate the terminal through the authorized authentication center. Only terminals that have passed the authentication and authorization can obtain electronic prescriptions. The operation authority, wherein, the authentication method of the authorized authentication center to the terminal can be the legitimacy of the public key of the patient or pharmaceutical company or doctor sent by the authentication terminal.

步骤601：病人终端获取病人信息发送至药企终端，向药企终端发送药物 清单请求，获取药企终端返回的与病人信息对应的药物清单，其中，病人信 息包括病人的基本个人信息及症状。Step 601: The patient terminal obtains the patient information and sends it to the pharmaceutical company terminal, sends a drug list request to the pharmaceutical company terminal, and obtains the drug list corresponding to the patient information returned by the pharmaceutical company terminal. The patient information includes the patient's basic personal information and symptoms.

需要说明的是，步骤601与步骤101一致，在此不进行详细赘述。。It should be noted that step 601 is consistent with step 101 and will not be described in detail here. .

步骤602：病人终端将病人信息和药物清单发送至医师终端，向医师终端 发送医师用药意见请求。Step 602: The patient terminal sends the patient information and drug list to the doctor terminal, and sends the doctor's medication opinion request to the doctor terminal.

需要说明的是，步骤602与步骤102一致，在此不进行详细赘述。It should be noted that step 602 is consistent with step 102 and will not be described in detail here.

步骤603：病人终端获取到医师终端返回的与病人信息和药物清单对应的 医师用药意见，生成包括病人信息、药物清单和医师用药意见的电子处方。Step 603: The patient terminal obtains the doctor's medication advice corresponding to the patient information and drug list returned by the doctor terminal, and generates an electronic prescription including the patient information, drug list, and doctor's medication advice.

需要说明的是，步骤603与步骤103一致，在此不进行详细赘述。It should be noted that step 603 is consistent with step 103 and will not be described in detail here.

步骤604：病人终端将电子处方发送至具有智能合约的医疗联盟区块链， 使得医疗联盟区块链对电子处方进行存储和共享。Step 604: The patient terminal sends the electronic prescription to the medical alliance blockchain with smart contracts, so that the medical alliance blockchain can store and share the electronic prescription.

需要说明的是，步骤604与步骤204一致，在此不进行详细赘述。It should be noted that step 604 is consistent with step 204, and will not be described in detail here.

进一步地，病人信息包括病人的病人数字签名，药物清单包括提供药物 清单的药企的药企数字签名，医师用药意见包括医师的医师数字签名。Further, the patient information includes the patient's digital signature, the drug list includes the digital signature of the pharmaceutical company that provided the drug list, and the physician's medication opinion includes the physician's digital signature.

需要说明的是，病人信息除了病人的个人信息和症状之外，还应包包括 病人的病人数字签名，以为病人信息的来源提供可靠的依据，防止有人恶意 提供看病信息；药物清单除了包括药物信息之外，还应包包括提供药物清单 的药企的药企数字签名，以为该药物清单提供真实依据，防止药物清单被恶 意冒用，无法追根溯源。同理，医师的医师用药意见中也应当包包括提供用 药意见的医师数字签名，以为该医师用药意见提供真实凭据，防止医师用药 意见被恶意冒用，防止病人或药企等对医师用药意见存在疑问时，无法找到 开具该医师用药意见的医师。It should be noted that in addition to the patient's personal information and symptoms, the patient information should also include the patient's digital signature to provide a reliable basis for the source of the patient information and prevent anyone from maliciously providing medical information; In addition, the digital signature of the pharmaceutical company that provided the drug list should also be included to provide a real basis for the drug list and prevent the drug list from being used maliciously and cannot be traced back to the source. Similarly, the physician's medication opinion should also include the digital signature of the physician who provided the medication opinion, so as to provide real evidence for the physician's medication opinion, prevent the doctor's medication opinion from being maliciously used, and prevent patients or pharmaceutical companies from having any opinions on the doctor's medication opinion. When in doubt, the physician who issued the physician's medication opinion cannot be found.

为了便于理解，请参阅图7，本发明提供的一种开具电子处方的系统的一 个实施例，用于实现上述的开具电子处方的方法，其特征在于，包括：病人 终端701、药企终端702、医师终端703、授权认证中心704和医疗联盟区块 链705；For ease of understanding, please refer to FIG. 7 , an embodiment of a system for issuing electronic prescriptions provided by the present invention, which is used to implement the above-mentioned method for issuing electronic prescriptions, is characterized in that it includes: a patient terminal 701, a pharmaceutical company terminal 702 , physician terminal 703, authorized authentication center 704 and medical alliance block chain 705;

病人终端701，用于获取病人的病人信息发送至药企终端702，向药企终 端702发送药物清单请求，获取药企终端702返回的药物清单，其中，病人 信息包括病人的基本个人信息及症状；The patient terminal 701 is used to obtain the patient's patient information and send it to the pharmaceutical company terminal 702, send a drug list request to the pharmaceutical company terminal 702, and obtain the drug list returned by the pharmaceutical company terminal 702, wherein the patient information includes the patient's basic personal information and symptoms ;

病人终端701，还用于将病人信息和药物清单发送至医师终端703，向医 师终端703发送医师用药意见请求；The patient terminal 701 is also used to send the patient information and drug list to the doctor terminal 703, and send the doctor's medication opinion request to the doctor terminal 703;

病人终端701，还用于获取到医师终端703返回的医师用药意见，生成包 括病人信息、药物清单和医师用药意见的电子处方；The patient terminal 701 is also used to obtain the doctor's medication advice returned by the physician terminal 703, and generate an electronic prescription including patient information, drug list and doctor's medication advice;

药企终端702，用于获取病人终端发送的药物清单请求和病人信息，并向 病人终端返回药物清单。The pharmaceutical company terminal 702 is used to obtain the drug list request and patient information sent by the patient terminal, and return the drug list to the patient terminal.

医师终端703，用于获取病人终端发送的医师用药意见请求，病人信息和 药物清单，向病人终端返回医师用药意见。Physician terminal 703 is used to obtain the doctor's medication opinion request sent by the patient terminal, patient information and drug list, and return the doctor's medication opinion to the patient terminal.

授权认证中心704，用于验证医疗联盟区块链705的节点、病人终端701、 药企终端702和医师终端703的合法性。The authorized authentication center 704 is used to verify the legitimacy of the nodes of the medical alliance block chain 705, the patient terminal 701, the pharmaceutical company terminal 702 and the doctor terminal 703.

医疗联盟区块链705，用于记录病人终端701、药企终端702和医师终端 703三者之间的交易，触发智能合约，对电子处方进行处理。The medical alliance block chain 705 is used to record the transactions between the patient terminal 701, the pharmaceutical company terminal 702 and the doctor terminal 703, trigger the smart contract, and process the electronic prescription.

需要说明的是，授权认证中心704负责证明医疗联盟区块链705的节点、 病人终端701、药企终端702和医师终端703的合法性，医疗联盟区块链705 的节点、病人终端701、药企终端702和医师终端703自行生成非对称密钥后， 需要将医疗联盟区块链705的节点和病人终端701、药企终端702和医师终端 703的信息数据和公钥发送至授权认证中心704进行验证，验证通过后，由授 权认证中心704颁发数字证书，方可获得合法身份。医疗联盟区块链705的 节点是由可信、具有较强计算机能力及存储能力的医疗机构节点组成，加入 医疗联盟区块链705的节点所在的区块链首先需经过授权认证中心704授权， 颁发数字证书，才能获得相应的权利。医疗联盟区块链705的节点负责记录 电子处方使用终端，即病人终端701和/或药企终端702和/或医师终端703的 操作，并触发智能合约，完成电子处方各项功能。It should be noted that the authorized certification center 704 is responsible for proving the legitimacy of the nodes of the medical alliance blockchain 705, the patient terminal 701, the pharmaceutical enterprise terminal 702 and the physician terminal 703, the nodes of the medical alliance blockchain 705, the patient terminal After the enterprise terminal 702 and the physician terminal 703 generate the asymmetric key by themselves, they need to send the information data and public key of the nodes of the medical alliance blockchain 705, the patient terminal 701, the pharmaceutical enterprise terminal 702 and the physician terminal 703 to the authorized authentication center 704 After the verification is passed, the authorized authentication center 704 issues a digital certificate to obtain a legal identity. The nodes of the medical alliance blockchain 705 are composed of credible medical institution nodes with strong computer capabilities and storage capabilities. The blockchain where the nodes joining the medical alliance blockchain 705 must first be authorized by the authorized certification center 704, Only by issuing a digital certificate can the corresponding rights be obtained. The nodes of the medical alliance block chain 705 are responsible for recording the operation of the electronic prescription use terminal, that is, the operation of the patient terminal 701 and/or the pharmaceutical company terminal 702 and/or the doctor terminal 703, and trigger the smart contract to complete various functions of the electronic prescription.

所属领域的技术人员可以清楚地了解到，为描述的方便和简洁，上述描 述的系统，装置和单元的具体工作过程，可以参考前述方法实施例中的对应 过程，在此不再赘述。Those skilled in the art can clearly understand that for the convenience and brevity of description, the specific working process of the above-described system, device and unit can refer to the corresponding process in the foregoing method embodiment, and will not be repeated here.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.4